Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Authors
Keywords
-
Journal
NATURE METHODS
Volume 13, Issue 6, Pages 521-527
Publisher
Springer Nature
Online
2016-05-03
DOI
10.1038/nmeth.3853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell shape and the microenvironment regulate nuclear translocation of NF- B in breast epithelial and tumor cells
- (2015) J. E. Sero et al. Molecular Systems Biology
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- Patient-derived models of acquired resistance can identify effective drug combinations for cancer
- (2014) Adam S. Crystal et al. SCIENCE
- An open investigation of the reproducibility of cancer biology research
- (2014) Timothy M Errington et al. eLife
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Metrics other than potency reveal systematic variation in responses to cancer drugs
- (2013) Mohammad Fallahi-Sichani et al. Nature Chemical Biology
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
- (2012) Taru Muranen et al. CANCER CELL
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis
- (2012) Hang Yuan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Mitosis and Antimitotic Drug Responses in Tumors by In Vivo Microscopy and Single-Cell Pharmacodynamics
- (2011) J. D. Orth et al. CANCER RESEARCH
- Subtype and pathway specific responses to anticancer compounds in breast cancer
- (2011) L. M. Heiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical Biology Meets Biological Chemistry Minireview Series
- (2010) Benjamin F. Cravatt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guidelines for accurate EC50/IC50 estimation
- (2010) J. L. Sebaugh PHARMACEUTICAL STATISTICS
- High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells
- (2009) Hyung-song Nam et al. Cell Stem Cell
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
- (2009) Dirk Hockemeyer et al. NATURE BIOTECHNOLOGY
- Tunable interplay between epidermal growth factor and cell-cell contact governs the spatial dynamics of epithelial growth
- (2009) J.-H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
- Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
- (2008) J. Shi et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More